drugset / Trial / NCT07669077

A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women

NCT07669077

Phase 1 Recruiting 8 enrolled Janssen Research & Development, LLC
NaSingle-groupOpen-labelTreatment

Summary

The main purpose of this study is to assess the concentrations of nipocalimab (pharmacokinetics \[PK\]) in the breast milk after administration of a single dose of nipocalimab into the vein, in healthy lactating women.

Timeline

Start
2026-06-26
Primary completion
2027-02-16
Completion
2027-02-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Nipocalimab Monoclonal antibody Intravenous

Indications

No indication recorded.